TEHRAN (Tasnim) A specific type of multiple sclerosis (MS) drug, called the BG-12, will be produced inside Iran within months, an official announced.   An Iranian pharmaceutical company is set to produce the BG-12 within the next two or three months, Hamid Reza Torabi, secretary of Irans 11th MS Congress said on Tuesday. He also ...